MAPT and Alzheimer disease: In the present study, the AD group showed tau hyperphosphorylation, reduced levels of synaptic plasticity markers such as BDNF, PSD95, and synaptophysin, reduced cell proliferation and neurogenesis, reduced mitochondrial Ca2+ retention, and elevated H2O2.